Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2015 |
| Start Date: | September 2013 |
| End Date: | March 2016 |
| Contact: | David J Whellan, MD MHS |
| Email: | david.whellan@jefferson.edu |
| Phone: | 215 955 2007 |
Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in Heart Failure Patients (CONFIRM-HF)
A research study to determine if heart failure can be medically managed using data collected
from cardiac monitoring devices
from cardiac monitoring devices
Inclusion Criteria:
- At least 18 years of age
- Admission for worsening of HF
- Discharged to home
- Have appropriate cardiac device with OptiVol® implanted for at least 34 days prior to
enrollment
- Enrolled in Carelink® system and able to transmit data
- Able to participate for at least 3 months
Exclusion Criteria:
- Post heart transplant or actively listed
- End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left
ventricular assist device support
- Stage IV or V chronic renal dysfunction (GFR <25 mol/min per 1.73 M2)
- Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen
- Severe pulmonary hypertension not due to left-sided HF
We found this trial at
1
site
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
